MBL-deficient adults are characterized by a higher risk, severity, and frequency of infections in a number of clinical settings, although the exact impact of this kind of innate immunodeficiency on the clinical outcome is still poorly understood [66, 67]. This evidence concerns the gene MBL2 and infection.